Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19-related Acute Respiratory Distress Syndrome: Worth the Effort?
Falcoz et al discuss their study on extracorporeal membrane oxygenation for critically ill patients with COVID-19-related acute respiratory distress syndrome. The study involved patients referred to the five ICUs of the Strasbourg University Hospital, between March 3 and April 1, 2020, for severe AR...
Gespeichert in:
| Veröffentlicht in: | American journal of respiratory and critical care medicine 2020-08, Vol.202 (3), p.460-463 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 463 |
|---|---|
| container_issue | 3 |
| container_start_page | 460 |
| container_title | American journal of respiratory and critical care medicine |
| container_volume | 202 |
| creator | Falcoz, Pierre-Emmanuel Monnier, Alexandra Puyraveau, Marc Perrier, Stephanie Ludes, Pierre-Olivier Olland, Anne Mertes, Paul-Michel Schneider, Francis Helms, Julie Meziani, Ferhat |
| description | Falcoz et al discuss their study on extracorporeal membrane oxygenation for critically ill patients with COVID-19-related acute respiratory distress syndrome. The study involved patients referred to the five ICUs of the Strasbourg University Hospital, between March 3 and April 1, 2020, for severe ARDS due to COVID-19 (confirmed by RT-PCR test), and that had been supported by extracorporeal membrane oxygenation (ECMO) after failure of optimal medical treatment, including neuromuscular blocking agents, protective ventilation, and high positive end-expiratory pressure (PEEP). The results revealed that although venovenous-ECMO is burdened with a high rate of life-threatening complications, it might be considered as a rescue therapy in refractory COVID-19 ARDS. |
| doi_str_mv | 10.1164/rccm.202004-1370LE |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7397791</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2430685688</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-254e1ea6d2a3b759506a1d863a9d8508ae9dece6ec0702ac40f0bc6b1705b2ed3</originalsourceid><addsrcrecordid>eNpdkstu1DAUhiMEoqXwAiyQJTawSDmOHTthARpNBzrSoEHcd5bjnHRSJfFgO6V5Bx4aj1Iq6MpHPt9_bvqT5CmFU0oFf-WM6U8zyAB4SpmEzepeckxzlqe8lHA_xiBZynn54yh55P0lAM0KCg-TI5blnGVQHCe_V9fBaWPd3jrUHfmAfeX0gGR7PV3goENrB9JYR5auDa3RXTeRddeRjzGDQ_DkVxt2ZLn9tj5LaZk67HTAmizMGJB8Qr9vnQ7WTeSs9cGh9-TzNNTO9viafLcuasMOyaqJLcLbx8mDRncen9y8J8nXd6svy_N0s32_Xi42qeGChzQOjxS1qDPNKpmXOQhN60IwXdZFDoXGskaDAg1IyLTh0EBlREUl5FWGNTtJ3sx192PVY23iIk53au_aXrtJWd2q_zNDu1MX9kpJVkpZ0ljg5Vxgd0d2vtiowx8wwaEQ8urAvrhp5uzPEX1QfesNdl28sh29yjjlAEwKFtHnd9BLO7ohniJSDESRi6KIVDZTxlnvHTa3E1BQB2OogzHUbAw1GyOKnv278q3krxPYH-4XtsU</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2430685688</pqid></control><display><type>article</type><title>Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19-related Acute Respiratory Distress Syndrome: Worth the Effort?</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>American Thoracic Society (ATS) Journals Online</source><source>Alma/SFX Local Collection</source><creator>Falcoz, Pierre-Emmanuel ; Monnier, Alexandra ; Puyraveau, Marc ; Perrier, Stephanie ; Ludes, Pierre-Olivier ; Olland, Anne ; Mertes, Paul-Michel ; Schneider, Francis ; Helms, Julie ; Meziani, Ferhat</creator><creatorcontrib>Falcoz, Pierre-Emmanuel ; Monnier, Alexandra ; Puyraveau, Marc ; Perrier, Stephanie ; Ludes, Pierre-Olivier ; Olland, Anne ; Mertes, Paul-Michel ; Schneider, Francis ; Helms, Julie ; Meziani, Ferhat</creatorcontrib><description>Falcoz et al discuss their study on extracorporeal membrane oxygenation for critically ill patients with COVID-19-related acute respiratory distress syndrome. The study involved patients referred to the five ICUs of the Strasbourg University Hospital, between March 3 and April 1, 2020, for severe ARDS due to COVID-19 (confirmed by RT-PCR test), and that had been supported by extracorporeal membrane oxygenation (ECMO) after failure of optimal medical treatment, including neuromuscular blocking agents, protective ventilation, and high positive end-expiratory pressure (PEEP). The results revealed that although venovenous-ECMO is burdened with a high rate of life-threatening complications, it might be considered as a rescue therapy in refractory COVID-19 ARDS.</description><identifier>ISSN: 1073-449X</identifier><identifier>EISSN: 1535-4970</identifier><identifier>DOI: 10.1164/rccm.202004-1370LE</identifier><identifier>PMID: 32543208</identifier><language>eng</language><publisher>United States: American Thoracic Society</publisher><subject>Adult ; Aged ; Betacoronavirus ; Coronavirus Infections - complications ; Coronavirus Infections - mortality ; Coronavirus Infections - therapy ; Correspondence ; COVID-19 ; Critical Care ; Extracorporeal Membrane Oxygenation ; Female ; Humans ; Life Sciences ; Male ; Medical treatment ; Middle Aged ; Oxygen ; Pandemics ; Pneumonia, Viral - complications ; Pneumonia, Viral - mortality ; Pneumonia, Viral - therapy ; Respiratory distress syndrome ; Respiratory Distress Syndrome - mortality ; Respiratory Distress Syndrome - therapy ; Respiratory Distress Syndrome - virology ; Santé publique et épidémiologie ; SARS-CoV-2 ; Treatment Outcome</subject><ispartof>American journal of respiratory and critical care medicine, 2020-08, Vol.202 (3), p.460-463</ispartof><rights>Copyright American Thoracic Society Aug 1, 2020</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>Copyright © 2020 by the American Thoracic Society 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-254e1ea6d2a3b759506a1d863a9d8508ae9dece6ec0702ac40f0bc6b1705b2ed3</citedby><cites>FETCH-LOGICAL-c464t-254e1ea6d2a3b759506a1d863a9d8508ae9dece6ec0702ac40f0bc6b1705b2ed3</cites><orcidid>0000-0002-7481-5101</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,4011,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32543208$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-03640867$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Falcoz, Pierre-Emmanuel</creatorcontrib><creatorcontrib>Monnier, Alexandra</creatorcontrib><creatorcontrib>Puyraveau, Marc</creatorcontrib><creatorcontrib>Perrier, Stephanie</creatorcontrib><creatorcontrib>Ludes, Pierre-Olivier</creatorcontrib><creatorcontrib>Olland, Anne</creatorcontrib><creatorcontrib>Mertes, Paul-Michel</creatorcontrib><creatorcontrib>Schneider, Francis</creatorcontrib><creatorcontrib>Helms, Julie</creatorcontrib><creatorcontrib>Meziani, Ferhat</creatorcontrib><title>Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19-related Acute Respiratory Distress Syndrome: Worth the Effort?</title><title>American journal of respiratory and critical care medicine</title><addtitle>Am J Respir Crit Care Med</addtitle><description>Falcoz et al discuss their study on extracorporeal membrane oxygenation for critically ill patients with COVID-19-related acute respiratory distress syndrome. The study involved patients referred to the five ICUs of the Strasbourg University Hospital, between March 3 and April 1, 2020, for severe ARDS due to COVID-19 (confirmed by RT-PCR test), and that had been supported by extracorporeal membrane oxygenation (ECMO) after failure of optimal medical treatment, including neuromuscular blocking agents, protective ventilation, and high positive end-expiratory pressure (PEEP). The results revealed that although venovenous-ECMO is burdened with a high rate of life-threatening complications, it might be considered as a rescue therapy in refractory COVID-19 ARDS.</description><subject>Adult</subject><subject>Aged</subject><subject>Betacoronavirus</subject><subject>Coronavirus Infections - complications</subject><subject>Coronavirus Infections - mortality</subject><subject>Coronavirus Infections - therapy</subject><subject>Correspondence</subject><subject>COVID-19</subject><subject>Critical Care</subject><subject>Extracorporeal Membrane Oxygenation</subject><subject>Female</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Medical treatment</subject><subject>Middle Aged</subject><subject>Oxygen</subject><subject>Pandemics</subject><subject>Pneumonia, Viral - complications</subject><subject>Pneumonia, Viral - mortality</subject><subject>Pneumonia, Viral - therapy</subject><subject>Respiratory distress syndrome</subject><subject>Respiratory Distress Syndrome - mortality</subject><subject>Respiratory Distress Syndrome - therapy</subject><subject>Respiratory Distress Syndrome - virology</subject><subject>Santé publique et épidémiologie</subject><subject>SARS-CoV-2</subject><subject>Treatment Outcome</subject><issn>1073-449X</issn><issn>1535-4970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkstu1DAUhiMEoqXwAiyQJTawSDmOHTthARpNBzrSoEHcd5bjnHRSJfFgO6V5Bx4aj1Iq6MpHPt9_bvqT5CmFU0oFf-WM6U8zyAB4SpmEzepeckxzlqe8lHA_xiBZynn54yh55P0lAM0KCg-TI5blnGVQHCe_V9fBaWPd3jrUHfmAfeX0gGR7PV3goENrB9JYR5auDa3RXTeRddeRjzGDQ_DkVxt2ZLn9tj5LaZk67HTAmizMGJB8Qr9vnQ7WTeSs9cGh9-TzNNTO9viafLcuasMOyaqJLcLbx8mDRncen9y8J8nXd6svy_N0s32_Xi42qeGChzQOjxS1qDPNKpmXOQhN60IwXdZFDoXGskaDAg1IyLTh0EBlREUl5FWGNTtJ3sx192PVY23iIk53au_aXrtJWd2q_zNDu1MX9kpJVkpZ0ljg5Vxgd0d2vtiowx8wwaEQ8urAvrhp5uzPEX1QfesNdl28sh29yjjlAEwKFtHnd9BLO7ohniJSDESRi6KIVDZTxlnvHTa3E1BQB2OogzHUbAw1GyOKnv278q3krxPYH-4XtsU</recordid><startdate>20200801</startdate><enddate>20200801</enddate><creator>Falcoz, Pierre-Emmanuel</creator><creator>Monnier, Alexandra</creator><creator>Puyraveau, Marc</creator><creator>Perrier, Stephanie</creator><creator>Ludes, Pierre-Olivier</creator><creator>Olland, Anne</creator><creator>Mertes, Paul-Michel</creator><creator>Schneider, Francis</creator><creator>Helms, Julie</creator><creator>Meziani, Ferhat</creator><general>American Thoracic Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7481-5101</orcidid></search><sort><creationdate>20200801</creationdate><title>Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19-related Acute Respiratory Distress Syndrome: Worth the Effort?</title><author>Falcoz, Pierre-Emmanuel ; Monnier, Alexandra ; Puyraveau, Marc ; Perrier, Stephanie ; Ludes, Pierre-Olivier ; Olland, Anne ; Mertes, Paul-Michel ; Schneider, Francis ; Helms, Julie ; Meziani, Ferhat</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-254e1ea6d2a3b759506a1d863a9d8508ae9dece6ec0702ac40f0bc6b1705b2ed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Betacoronavirus</topic><topic>Coronavirus Infections - complications</topic><topic>Coronavirus Infections - mortality</topic><topic>Coronavirus Infections - therapy</topic><topic>Correspondence</topic><topic>COVID-19</topic><topic>Critical Care</topic><topic>Extracorporeal Membrane Oxygenation</topic><topic>Female</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Medical treatment</topic><topic>Middle Aged</topic><topic>Oxygen</topic><topic>Pandemics</topic><topic>Pneumonia, Viral - complications</topic><topic>Pneumonia, Viral - mortality</topic><topic>Pneumonia, Viral - therapy</topic><topic>Respiratory distress syndrome</topic><topic>Respiratory Distress Syndrome - mortality</topic><topic>Respiratory Distress Syndrome - therapy</topic><topic>Respiratory Distress Syndrome - virology</topic><topic>Santé publique et épidémiologie</topic><topic>SARS-CoV-2</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Falcoz, Pierre-Emmanuel</creatorcontrib><creatorcontrib>Monnier, Alexandra</creatorcontrib><creatorcontrib>Puyraveau, Marc</creatorcontrib><creatorcontrib>Perrier, Stephanie</creatorcontrib><creatorcontrib>Ludes, Pierre-Olivier</creatorcontrib><creatorcontrib>Olland, Anne</creatorcontrib><creatorcontrib>Mertes, Paul-Michel</creatorcontrib><creatorcontrib>Schneider, Francis</creatorcontrib><creatorcontrib>Helms, Julie</creatorcontrib><creatorcontrib>Meziani, Ferhat</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of respiratory and critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Falcoz, Pierre-Emmanuel</au><au>Monnier, Alexandra</au><au>Puyraveau, Marc</au><au>Perrier, Stephanie</au><au>Ludes, Pierre-Olivier</au><au>Olland, Anne</au><au>Mertes, Paul-Michel</au><au>Schneider, Francis</au><au>Helms, Julie</au><au>Meziani, Ferhat</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19-related Acute Respiratory Distress Syndrome: Worth the Effort?</atitle><jtitle>American journal of respiratory and critical care medicine</jtitle><addtitle>Am J Respir Crit Care Med</addtitle><date>2020-08-01</date><risdate>2020</risdate><volume>202</volume><issue>3</issue><spage>460</spage><epage>463</epage><pages>460-463</pages><issn>1073-449X</issn><eissn>1535-4970</eissn><abstract>Falcoz et al discuss their study on extracorporeal membrane oxygenation for critically ill patients with COVID-19-related acute respiratory distress syndrome. The study involved patients referred to the five ICUs of the Strasbourg University Hospital, between March 3 and April 1, 2020, for severe ARDS due to COVID-19 (confirmed by RT-PCR test), and that had been supported by extracorporeal membrane oxygenation (ECMO) after failure of optimal medical treatment, including neuromuscular blocking agents, protective ventilation, and high positive end-expiratory pressure (PEEP). The results revealed that although venovenous-ECMO is burdened with a high rate of life-threatening complications, it might be considered as a rescue therapy in refractory COVID-19 ARDS.</abstract><cop>United States</cop><pub>American Thoracic Society</pub><pmid>32543208</pmid><doi>10.1164/rccm.202004-1370LE</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-7481-5101</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1073-449X |
| ispartof | American journal of respiratory and critical care medicine, 2020-08, Vol.202 (3), p.460-463 |
| issn | 1073-449X 1535-4970 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7397791 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; American Thoracic Society (ATS) Journals Online; Alma/SFX Local Collection |
| subjects | Adult Aged Betacoronavirus Coronavirus Infections - complications Coronavirus Infections - mortality Coronavirus Infections - therapy Correspondence COVID-19 Critical Care Extracorporeal Membrane Oxygenation Female Humans Life Sciences Male Medical treatment Middle Aged Oxygen Pandemics Pneumonia, Viral - complications Pneumonia, Viral - mortality Pneumonia, Viral - therapy Respiratory distress syndrome Respiratory Distress Syndrome - mortality Respiratory Distress Syndrome - therapy Respiratory Distress Syndrome - virology Santé publique et épidémiologie SARS-CoV-2 Treatment Outcome |
| title | Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19-related Acute Respiratory Distress Syndrome: Worth the Effort? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T09%3A11%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Extracorporeal%20Membrane%20Oxygenation%20for%20Critically%20Ill%20Patients%20with%20COVID-19-related%20Acute%20Respiratory%20Distress%20Syndrome:%20Worth%20the%20Effort?&rft.jtitle=American%20journal%20of%20respiratory%20and%20critical%20care%20medicine&rft.au=Falcoz,%20Pierre-Emmanuel&rft.date=2020-08-01&rft.volume=202&rft.issue=3&rft.spage=460&rft.epage=463&rft.pages=460-463&rft.issn=1073-449X&rft.eissn=1535-4970&rft_id=info:doi/10.1164/rccm.202004-1370LE&rft_dat=%3Cproquest_pubme%3E2430685688%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2430685688&rft_id=info:pmid/32543208&rfr_iscdi=true |